Skip to Main Content

Author Details

Sunil K Joshi
Knight Cancer Institute, Oregon Health & Science University
1998
55
24
PMIDPaper TitleJournal TitlePublished Year
35896960Proteomic and phosphoproteomic measurements enhance ability to predict ex vivo drug response in AML.Clin Proteomics2022
36734985Oncoproteomic profiling of AML: moving beyond genomics.Expert Rev Proteomics2022
34171263The AML microenvironment catalyzes a stepwise evolution to gilteritinib resistance.Cancer Cell2021
33780043A noncanonical FLT3 gatekeeper mutation disrupts gilteritinib binding and confers resistance.Am J Hematol2021
32366937ERBB2/HER2 mutations are transforming and therapeutically targetable in leukemia.Leukemia2020
32021432Profile of Quizartinib for the Treatment of Adult Patients with Relapsed/Refractory FLT3-ITD-Positive Acute Myeloid Leukemia: Evidence to Date.Cancer Manag Res2020
32315394Discovery and characterization of targetable NTRK point mutations in hematologic neoplasms.Blood2020
31048320The TP53 Apoptotic Network Is a Primary Mediator of Resistance to BCL2 Inhibition in AML Cells.Cancer Discov2019
31711503Heterogeneity in HIV and cellular transcription profiles in cell line models of latent and productive infection: implications for HIV latency.Retrovirology2019
31551508Revisiting NTRKs as an emerging oncogene in hematological malignancies.Leukemia2019
30924767Correction: FGF2-FGFR1 signaling regulates release of leukemia-protective exosomes from bone marrow stromal cells.Elife2019
30933235Estimation of Study Time Reduction Using Surrogate End Points Rather Than Overall Survival in Oncology Clinical Trials.JAMA Intern Med2019
30720426FGF2-FGFR1 signaling regulates release of Leukemia-Protective exosomes from bone marrow stromal cells.Elife2019
29491188HIV latency in isolated patient CD4<sup>+</sup> T cells may be due to blocks in HIV transcriptional elongation, completion, and splicing.Sci Transl Med2018
29581250LSD1 activates a lethal prostate cancer gene network independently of its demethylase function.Proc Natl Acad Sci U S A2018
28034670Assays for precise quantification of total (including short) and elongated HIV-1 transcripts.J Virol Methods2017
28331061An intracellular matrix metalloproteinase-2 isoform induces tubular regulated necrosis: implications for acute kidney injury.Am J Physiol Renal Physiol2017
28936485A Randomized Controlled Trial of Lisinopril to Decrease Lymphoid Fibrosis in Antiretroviral-Treated, HIV-infected Individuals.Pathog Immun2017
28822963α<sub>1A</sub>-Subtype adrenergic agonist therapy for the failing right ventricle.Am J Physiol Heart Circ Physiol2017
26213293Novel intracellular N-terminal truncated matrix metalloproteinase-2 isoform in skeletal muscle ischemia-reperfusion injury.J Orthop Res2016
26322923Immunosuppression With FTY720 Reverses Cardiac Dysfunction in Hypomorphic ApoE Mice Deficient in SR-BI Expression That Survive Myocardial Infarction Caused by Coronary Atherosclerosis.J Cardiovasc Pharmacol2016
25767782Matrix metalloproteinase-2 plays a critical role in overload induced skeletal muscle hypertrophy.Muscles Ligaments Tendons J2015
26379248Two Distinct Isoforms of Matrix Metalloproteinase-2 Are Associated with Human Delayed Kidney Graft Function.PLoS One2015
26261790Bone morphogenetic protein signaling in rotator cuff muscle atrophy and fatty infiltration.Muscles Ligaments Tendons J2015
26120785Immunization of Mice with Anthrax Protective Antigen Limits Cardiotoxicity but Not Hepatotoxicity Following Lethal Toxin Challenge.Toxins (Basel)2015
24018537Differential ubiquitin-proteasome and autophagy signaling following rotator cuff tears and suprascapular nerve injury.J Orthop Res2014
25436890Novel mouse model of spinal cord injury-induced heterotopic ossification.J Rehabil Res Dev2014
25489556Matrix metalloproteinase-2 plays a critical role in overload induced skeletal muscle hypertrophy.Muscles Ligaments Tendons J2014
24875732Upregulation of transforming growth factor-β signaling in a rat model of rotator cuff tears.J Shoulder Elbow Surg2014
23239524mTOR regulates fatty infiltration through SREBP-1 and PPARγ after a combined massive rotator cuff tear and suprascapular nerve injury in rats.J Orthop Res2013
23885343Original article Muscle extracellular matrix degradation and contractibility following tendon rupture and disuse.Muscles Ligaments Tendons J2013
23659607Peripheral nerve repair in rats using composite hydrogel-filled aligned nanofiber conduits with incorporated nerve growth factor.Tissue Eng Part A2013
23800654Fine tuning a well-oiled machine: Influence of NK1.1 and NKG2D on NKT cell development and function.Int Immunopharmacol2013
23797666BAFF- and APRIL-dependent maintenance of antibody titers after immunization with T-dependent antigen and CD1d-binding ligand.J Immunol2013
22378614Evaluation of Akt/mTOR activity in muscle atrophy after rotator cuff tears in a rat model.J Orthop Res2012
23164080Functional motor recovery after peripheral nerve repair with an aligned nanofiber tubular conduit in a rat model.Regen Med2012
22331103Differential contribution of dendritic cell CD1d to NKT cell-enhanced humoral immunity and CD8+ T cell activation.J Leukoc Biol2012
21398691Reduction of CD1d expression in vivo minimally affects NKT-enhanced antibody production but boosts B-cell memory.Int Immunol2011
21858226Regulation of anthrax toxin-specific antibody titers by natural killer T cell-derived IL-4 and IFNγ.PLoS One2011
21959330CD40L-null NKT cells provide B cell help for specific antibody responses.Vaccine2011
20123711CD1d-dependent B-cell help by NK-like T cells leads to enhanced and sustained production of Bacillus anthracis lethal toxin-neutralizing antibodies.Infect Immun2010
20498261CD4 T-cell suppression by cells from Toxoplasma gondii-infected retinas is mediated by surface protein PD-L1.Infect Immun2010
19779559Bacillus anthracis lethal toxin disrupts TCR signaling in CD1d-restricted NKT cells leading to functional anergy.PLoS Pathog2009
16574228GCSF receptor regulates antigen uptake and expression of cytokines and costimulatory molecules in dendritic cells.Mol Immunol2007
16960577The autoimmune regulator (Aire) controls iNKT cell development and maturation.Nat Med2006
16732280The autoimmune regulator (Aire) controls iNKT cell development and maturation.Nat Med2006
16709807Conditional ablation of MHC-II suggests an indirect role for MHC-II in regulatory CD4 T cell maintenance.J Immunol2006
15705791Constitutive homing of mast cell progenitors to the intestine depends on autologous expression of the chemokine receptor CXCR2.Blood2005
11857806A conditional null allele of the major histocompatibility IA-beta chain gene.Genesis2002
12001069Induced DNA recombination by Cre recombinase protein transduction.Genesis2002
  • 1 - 50 of 55

Recommended Authors

Nottingham Trent University
Career Start Year 2010
Number of shared co-authors 0
Texas Children's Cancer Center
Career Start Year 2010
Number of shared co-authors 0
City of Hope National Medical Center
Career Start Year 2009
Number of shared co-authors 0
Institute of Biomedical Science and Children's Hospital, Fudan University
Career Start Year 2006
Number of shared co-authors 0
National Institute of Arthritis
Career Start Year 2005
Number of shared co-authors 1
Washington University School of Medicine
Career Start Year 2003
Number of shared co-authors 0
University of Alabama at Birmingham
Career Start Year 2000
Number of shared co-authors 0
Center for Cancer Research
Career Start Year 1999
Number of shared co-authors 0
Purdue University
Career Start Year 1999
Number of shared co-authors 0
Merck & Co.
Career Start Year 1998
Number of shared co-authors 2
Transplant Research Center, Brigham and Women's Hospital, Harvard Medical School
Career Start Year 1998
Number of shared co-authors 0
College of Science & Industry Convergence, Ewha Womans University
Career Start Year 1997
Number of shared co-authors 0
The Ohio State University
Career Start Year 1997
Number of shared co-authors 0
Icahn School of Medicine at Mount Sinai
Career Start Year 1996
Number of shared co-authors 0
University of California Los Angeles
Career Start Year 1994
Number of shared co-authors 0
The University of Danang-University of Science and Technology
Career Start Year 1993
Number of shared co-authors 0
Caryl and Israel Englander Institute for Precision Medicine.
Career Start Year 1993
Number of shared co-authors 0
Zhengzhou University
Career Start Year 1992
Number of shared co-authors 1
Universite de Montreal
Career Start Year 1991
Number of shared co-authors 0
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1991
Number of shared co-authors 0
Princess Margaret Cancer Centre, Ontario Cancer Institute, University Health Network
Career Start Year 1989
Number of shared co-authors 0
St. Jude Children's Research Hospital
Career Start Year 1989
Number of shared co-authors 0
Helen Wills Neuroscience Institute, University of California berkeley
Career Start Year 1988
Number of shared co-authors 0
Institute for Research in Immunology and Cancer (IRIC), University of Montreal
Career Start Year 1986
Number of shared co-authors 0
Stanford University School of Medicine
Career Start Year 1985
Number of shared co-authors 5
Hoag Memorial Hospital Presbyterian
Career Start Year 1983
Number of shared co-authors 1
Center for Molecular Imaging, University of Pittsburgh School of Medicine
Career Start Year 1981
Number of shared co-authors 0
University of Nebraska Medical Center
Career Start Year 1980
Number of shared co-authors 0
Princess Margaret Cancer Centre, University Health Network
Career Start Year 1970
Number of shared co-authors 0
RIKEN Center for Integrative Medical Sciences (IMS)
Career Start Year 1966
Number of shared co-authors 0

Collaborators

Oregon Health & Science University
Co-authored papers 10
Oregon Health & Science University
Co-authored papers 8
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 8
Oregon Health & Science University School of Medicine
Co-authored papers 7
Oregon Health & Science University, University of California Berkeley
Co-authored papers 6
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 4
Oregon Health and Science University
Co-authored papers 3
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 3
Oregon Health Sciences University
Co-authored papers 2
University of Colorado Anschutz Medical Campus
Co-authored papers 2
Pacific Northwest National Laboratory
Co-authored papers 2
Pacific Northwest National Laboratory
Co-authored papers 2
Pacific Northwest National Laboratory
Co-authored papers 2
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 2
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 2
Exact Sciences Corporation
Co-authored papers 2
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 2
Pacific Northwest National Laboratory
Co-authored papers 2
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 2
Saint John's Cancer Institute (SJCI)
Co-authored papers 2
Knight Cancer Institute, Oregon Health and Science University
Co-authored papers 2
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 2
Pacific Northwest National Laboratory (PNNL)
Co-authored papers 2
Pacific Northwest National Laboratory
Co-authored papers 2
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 1
Oregon Health and Science University
Co-authored papers 1
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 1
Houston Methodist Research Institute
Co-authored papers 1
OHSU Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 1
Knight Cancer Institute.
Co-authored papers 1